AAV


Also found in: Acronyms, Wikipedia.

AAV

Abbreviation for adeno-associated virus.
Mentioned in ?
References in periodicals archive ?
The clinical stage biopharma company also appointed Phillip Maples, vice president of therapeutic development and quality management to oversee all cell-therapy manufacturing and Adam Davis as director to oversee AAV manufacturing.
At the World Government Summit in Dubai in February, EHANG and RTA announced a partnership to produce the AAV - know as the EHANG184 - with the aim of helping Dubai build the world's most intelligent transportation system.
The treatment with high doses of corticosteroid and cyclophosphamide may also contribute to VTE in AAV patients.
Abbreviations AAV: Adeno-associated virus [2] TA: Anterior tibial BDA: Biotinylated dextran amine BMS: Basso Mouse Scale CNS: Central nervous system CST: Corticospinal tract CTB: Cholera toxin B d: Day DRG: Dorsal root ganglia DPSNs: Descending propriospinal neurons FG: Fluoro-Gold GAP43: Growth-associated protein GFAP: Glial fibrillary acidic protein KLF7: Kruppel-like factor 7 [1] NGF: Nerve growth factor [3] OL: Oligodendrocytes P0: Peripheral myelin protein zero PNs: Propriospinal neurons SCI: Spinal cord injury tcMMEP: Transcranial magnetic motor-evoked potentials TEM: Transmission electron microscope TrkA: Tyrosine kinase A w: Week.
Recombinant adeno-associated virus (AAV) vectors have emerged as a new vector for gene therapy, and they have been widely used in clinical trials to treat a variety of diseases.
This article chronicling the origin of AAV is based on research as well as telephone, e-mail, and written interviews of extant members of the original Board of Directors.
Both companies will continue to operate as separate entities but will share intellectual property with immediate plans to integrate Synpromics' technology with AskBio's AAV platform ecosystem and current therapeutics portfolio under development.
Although March 2019 was her last issue for the journal, the AAV is greatly indebted to her for her years of dedication to both the journal and the AAV.
The agreement with Brammer Bio provides Sangamo with access to dedicated AAV manufacturing capacity up to 2000-L bioreactor scale capable of handling large-scale, commercial -grade runs for products such as ST-920, Sangamo's gene therapy product candidate for Fabry disease.
Although injecting viruses into humans may sound alarming, a large portion of the population already has been exposed to AAV with no harmful
"ABO-202 is an AAV gene therapy that has shown promising preclinical efficacy in the INCL animal model of disease by extending survival and improving muscle function when administered early in the disease course," noted Steven J.
Aldevron has launched an off-the-shelf version of pXX6-80, a common adeno-associated virus (AAV) helper plasmid.